GGrantIndex
Sort

39,280 grants matching leukemia

Project 2 - Genomics of Allogeneic Transplantation.

$436,241
John F Dipersio · Washington University · P01 · FY2023 · CA

Epigenetic drivers of cancer progression

$436,213
Andrew P Feinberg · Johns Hopkins University · R01 · FY2020 · CA

Biology of Alpha Particle Immunotherapy

$436,088
David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA

Biology of Alpha Particle Immunotherapy

$436,088
David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA

Eastern Cooperative Oncology Group

$436,068
Vanderbilt University · U10 · FY2004 · CA

Cellular factors in gammaretrovirus replication

$436,067
John A T Young · Salk Institute For Biological Studies · R01 · FY2008 · AI

Cellular factors in gammaretrovirus replication

$436,067
John A T Young · Salk Institute For Biological Studies · R01 · FY2009 · AI

Development and Function of Natural Autoreactive B Cells

$436,041
Kyoko Hayakawa · Research Inst Of Fox Chase Can Ctr · R01 · FY2009 · AI

Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling

$436,019
Jihong Bai · Fred Hutchinson Cancer Research Center · R01 · FY2020 · GM

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms

$436,000
Ann Mullally · Brigham And Women'S Hospital · R01 · FY2016 · HL

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms

$436,000
Ann Mullally · Brigham And Women'S Hospital · R01 · FY2019 · HL

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms

$436,000
Ann Mullally · Brigham And Women'S Hospital · R01 · FY2020 · HL

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms

$436,000
Ann Mullally · Brigham And Women'S Hospital · R01 · FY2017 · HL

Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.

$435,992
David Porter · University Of Pennsylvania · P01 · FY2017 · CA

Glucocorticoids in Lymphoblastic Leukemia

$435,991
Mary V. Relling · St. Jude Children'S Research Hospital · R01 · FY2010 · CA

PESTICIDES AND VDJ-RECOMBINASE MUTATIONS IN CHILD NHL

$435,980
University Of Southern California · R01 · FY2001 · CA

Development of SHP2 inhibitors for targeted anti-cancer therapy

$435,963
Zhong-Yin Zhang · Purdue University · R01 · FY2020 · CA

METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS

$435,948
Johns Hopkins University · R01 · FY2003 · CA

BCL11B activation as an approach for enhancing the efficacy of immunotherapy

$435,925
Chintan Parekh · Children'S Hospital Of Los Angeles · R01 · FY2021 · AI

Tyrosine Kinases and Thrombosis

$435,887
Alvin H Schmaier · Case Western Reserve University · R01 · FY2024 · HL

Control of Lineage Commitment in Developing Thymocytes

$435,886
Dietmar J Kappes · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · CA

Creation of a mouse model system for JC virus ORF4 protein

$435,875
Mahmut Safak · Temple Univ Of The Commonwealth · R21 · FY2025 · NS

3D co-culture system to characterize and target leukemia stem cells

$435,827
Monica L Guzman · Weill Medical Coll Of Cornell Univ · R21 · FY2020 · CA

T CELL TARGETING FOR GVHD

$435,801
Bruce R. Blazar · University Of Minnesota · R37 · FY2007 · HL

MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

$435,773
Leo Luznik · Johns Hopkins University · R01 · FY2012 · HL